Nakashima Masahiro, Nakayama Toshiyuki, Ohtsuru Akira, Fukada Eiichiro, Niino Daisuke, Yamazumi Kazuyuki, Naito Shinji, Ito Masahiro, Sekine Ichiro
Tissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Japan.
Pathol Res Pract. 2003;199(2):85-92. doi: 10.1078/0344-0338-00359.
Osteoclast-like giant cells (OCGC), which resemble osteoclasts at both the morphologic and immunohistochemical levels, develop in neoplastic tissue. In bone marrow, parathyroid hormone (PTH)-related peptide (PTHrP) can induce osteoclast differentiation by stimulating osteoclast progenitors through the PTH/PTHrP receptor (PPR). To evaluate the possible involvement of PTHrP in OCGC formation in tumors, we analyzed both PTHrP and PPR expression by immunohistochemistry in giant cell tumor of bone (GCTB) and anaplastic thyroid cancer (ATC) containing OCGC. In all cases of either GCTB (n = 5) or ATC (n = 4), intense stainingfor PTHrP was found in OCGC, but only faintly in mononuclear cells. PPR expression in OCGC was also demonstrated in 3 cases of GCTB and 2 cases of ATC. Double staining for PPR and proliferating cell nuclear antigen (PCNA) revealed that PPR was mainly expressed by PCNA-negative mononuclear cells and OCGC in these tumors. This suggests that OCGC might be derived from non-proliferating mononuclear cells by PTHrP stimulation via PPR. Furthermore, the profiles of PTHrP and PPR expression in OCGC were compared with those in the neoplastic GC found in malignancy (n = 6), osteoclasts in bone with osteoarthritis (n = 5), reactive GC, including Langhans-type and foreign body-type in pulmonary tuberculosis (n = 8), and ruptured epidermal cyst (n = 14) in order to clarify whether their distribution pattern was unique to OCGC. In all cases of malignancy, expression of both PTHrP and PPR was observed ubiquitously in neoplastic GC and mononuclear cells regardless of PCNA immunoreactivity. In contrast, in osteoclasts and reactive GC, PTHrP immunoreactivity was seen in all cases and in 7 of 22 cases, respectively, but no PPR expression was observed in either. In situ hybridization confirmed PTHrP expression at the transcriptional level in OCGC and neoplastic GC, but not in osteoclasts. Thus, although PTHrP expression was commonly observed in various types of multinucleated giant cells, their immunohistochemical profiles for PPR were distinct. We conclude that PPR might play a role during OCGC formation in GCTB and ATC.
破骨细胞样巨细胞(OCGC)在形态学和免疫组织化学水平上均类似于破骨细胞,在肿瘤组织中形成。在骨髓中,甲状旁腺激素(PTH)相关肽(PTHrP)可通过甲状旁腺激素/甲状旁腺激素相关肽受体(PPR)刺激破骨细胞祖细胞,从而诱导破骨细胞分化。为了评估PTHrP在肿瘤中OCGC形成过程中可能的作用,我们通过免疫组织化学分析了骨巨细胞瘤(GCTB)和含有OCGC的间变性甲状腺癌(ATC)中PTHrP和PPR的表达情况。在所有GCTB(n = 5)或ATC(n = 4)病例中,OCGC中均发现PTHrP染色强烈,但单核细胞中仅呈弱阳性。在3例GCTB和2例ATC中也证实了OCGC中有PPR表达。PPR与增殖细胞核抗原(PCNA)的双重染色显示,在这些肿瘤中,PPR主要由PCNA阴性的单核细胞和OCGC表达。这表明OCGC可能是由PTHrP通过PPR刺激非增殖性单核细胞产生的。此外,将OCGC中PTHrP和PPR的表达谱与恶性肿瘤中发现的肿瘤性巨细胞(n = 6)、骨关节炎患者骨中的破骨细胞(n = 5)、反应性巨细胞(包括肺结核中的朗汉斯型和异物型,n = 8)以及破裂的表皮样囊肿(n = 14)中的表达谱进行比较,以明确它们的分布模式是否为OCGC所特有。在所有恶性肿瘤病例中,无论PCNA免疫反应性如何,肿瘤性巨细胞和单核细胞中均普遍观察到PTHrP和PPR的表达。相反,在破骨细胞和反应性巨细胞中,分别在所有病例和22例中的7例中观察到PTHrP免疫反应性,但两者均未观察到PPR表达。原位杂交证实了OCGC和肿瘤性巨细胞中PTHrP在转录水平的表达,但破骨细胞中未观察到。因此,尽管在各种类型的多核巨细胞中普遍观察到PTHrP的表达,但其PPR的免疫组织化学谱却有所不同。我们得出结论,PPR可能在GCTB和ATC中OCGC的形成过程中发挥作用。